THE WRENN REPORT SPEAKS: HIPPA AND “THE DEA”

NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WALTER F. WRENN III., MD., JULIE KILLINGWORTH, LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., TERENCE SASAKI, MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS

BY

WALTER F. WRENN MD

Today, most States in America have instituted a drug monitoring program.The question we have to ask ourselves is whether this is a violation of HIPPA.

Who legally can access this data?

What role does the DEA play?

Is using this data to arrest and prosecute physicians a violation? I believe that it is a violation of HIPPA, as we understand it. The program was designed to prevent patients from receiving duplicate medication. For some reason, it became weaponized and has been used against physicians whose prescription practices differ from other physicians.

These agents solicited perjured statements from former employees who were forging prescriptions using my DEA license. They materially altered evidence in my case, including falsifying a police report and submitting an affidavit with false claims that were known to be untrue at the time of submission………JayK. Joshi, MD

The June 27, 2022, Ruan decision says that a physician cannot be accused of a crime when prescribing medication they are authorized to prescribe. Also, a physician cannot be charged with a crime just because his or her prescribing habits are different. All cases involving physicians using the Drug. Monitoring information which. Violating HIPPA should be dismissed.

Burden of pain
Dr. Jay K Joshi, physician, author, and entrepreneur, has released his debut book titled “Burden of Pain.” The book presents a unique perspective on the opioid epidemic, arguably the most pressing health issues of our time. “The DEA has shown a lack of willingness and an inability to uphold it standards of conduct. Oversight agencies have consistently shown repeated incidents of misconduct by DEA agents, with only a few receiving much, if any, accountability.”…..Jay K. Joshi MD
WALTER F. WRENN, MD

FOR NOW, YOU ARE WITHIN

DEA and HHS commit Constitutional violations against “suspect class” healthcare professionals for the pecuniary benefit of the DEA, HHS, Blue Cross Blue Shield Association, and/or the HFPP “Cartel”. 

THE NORM

DONATE LEGAL DEFENSE

OR SEND

$100, $250, 500 DOLLARS SEND 

TO ZELLE: 3135103378 OR CASH APP: $docnorm

OPIOID WARS
THE OPIOID WAR ON PATIENTS IN PAIN

5 Comments

  1. Only providers and pharmacists should be able to access the PDMP and then ONLY IN THE CAPACITY OF a specific patient’s care. In this I mean to check dosages filled and when of specific medications to verify patient records per patient verbal and written history in the doctor’s office and to check for any duplicate of therapy and cash purchases which would put the patient at risk for overdose.
    Pain and pain therapy can inhibit short term memory. This is not to be used to deny or accuse the patient unless a repeated pattern is discovered.
    The PDMP is a database for discovery and treatment for the provider and pharmacy NOT LAW ENFORCEMENT. It was meant to help facilitate safer therapy. Period. Not facilitate easier prosecutions.
    It was meant for in-house and continuance of care use only not to be infiltrated by outside sources. Why? To protect the privacy of the patient.
    If ANYONE ELSE IS TO ACCESS THIS SYSTEM, it was to require a subpoena. Not a warrant. And would need a very specific purpose and set of records. It was meant to be VERY DIFFICULT TO DO.
    ONLY THROUGH THE STATE BOARDS OF PHARMACY AND THEN WITH A LOT OF RED TAPE.

    RENEE

  2. The DEA will fight tooth and nail against anyone that tries to end their seemingly limitless access to the PDMP database. I mean, how else would they be able to do their job?

Leave a Reply to makarmanCancel reply